The French National Agency for Health Security (Anses) released a report on the risks linked to electronic cigarette use, revealing that approximately three million individuals in France vape. With an increasing prevalence noted among adults aged 18 to 79, the agency's report highlights both the everyday use of vaping devices and the associated health concerns raised by scientific literature. Experts utilized around 3,000 studies to underscore their findings, indicating a worrying trend among the population.

The agency delineated significant cardiovascular risks, such as elevated blood pressure and heart rate, which could suggest long-term cardiac issues for users. Furthermore, respiratory effects were also emphasized, including the potential for chronic obstructive pulmonary disease (COPD), a condition that progressively hinders breathing. This aspect of the analysis indicates an alarming trajectory for public health, as more people take up vaping without being fully aware of the consequences.

As vaping devices gain popularity, this report sheds light on the urgent need for public awareness and regulatory measures to mitigate these health risks. The findings also call for further research to understand the full scope of the implications of vaping on health, and how society can better protect individuals—especially younger generations—who might be increasingly inclined to use these devices, often under the misconception that they are a safer alternative to traditional smoking.